Cardiology
Co-Investigator
1)
lAC-051-302: A Double-Blind, Placebo-Controlled, Multicenter,
Randomized,
Parallel Design Study to Assess the Efficacy (Hemadynamics and
Symptoms) of RO
G1-0612 (Tezosentan) in Patients with Acute Decompensated Heart Failure,
1999.
2) Managed Care Lipid Treatment Assessment
Project (L-TAP) 1996.
3) Angio-Seal Hemostatic Puncture Closure
Device (IDEOG910028).
4) Holmium Angioplasty Randomized Trial in
Unstable Angina (1606).
5) NIR Vascular Advanced North American Trial
(NIRVANA Trial) (1818).
6)
SYMPHONY: A Phase III, Multicenter, International, Randomized,
Double-Blind, Aspirin-Controlled Trial to Evaluate the Efficacy and
Safety of Sibrafiban as Therapy for the Prevention of Secondary
Vascular Events in Patients after Acute Coronary Syndromes (BC 15574A)
(1853).
7)
A Randomized Comparison of the ACS Rx Multi-Link) Corona Stent System
with or without Abciximab vs. PTCA with or without Abciximab in the
Treatment of Patients with Acute Myocardial Infarction (ACS 96-304).
(1855).
8) Percutaneous Transluminal Myocardial
Revascularization (1886).
9)
A Multicenter Study of the Crossflex LC Balloon-Expandable Stent
Mounted on the
Valor OTW Delivery System in Patients with De Novo or Restenotic Native
Coronary
Artery or Saphenous Vein Graft Lesions.
10) A Single-Blind Randomized Study of the
Safety and Effectiveness of Percutaneous
Transluminal Myocardial Revascularization (PTMR) Performed with the
Eclipse:
Holmium Laser as an Adjunct to Percutaneous Coronary Intervention
(TMR012-A,
Version 3.1) (1945).
11) Study of the Safety and Effectiveness of
Percutaneous Transluminal Myocardial Revascularization in Patients with
Class III or IV Angina (ITMR014) (1952).
12) The 2' SYMPHONY Trial. A Phase III,
Multicenter, International Randomized,
Double-Blind, Aspirin-Controlled Trial to Evaluate the Efficacy and
Safety of Two
Regimens with Xubix (Sibrafiban, Ro43-3657), an Oral Platelet
Glycoprotein lib/Illa
Receptor Antagonist, as Therapy for the Long Term Prevention of
Secondary
Vascular Events in Patients after an Acute Coronary Syndrome. (1955).
13) NIR Post Approval Study (1983).
14) A Phase II,
Multicenter, Rndomized, Double Blind,
Placebo-controlled Pilot Trial Evaluating the Effects of
Infliximab(Remicade) in
Patients with Stable Class III or IV Congestive Heart Failure.
